| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kronos Bio, Inc. | Director | Stock Option (Right to Buy) | 34K | Jun 22, 2022 | Direct | ||
| Ikena Oncology, Inc. | Director | Stock Option (Right to Buy) | 17.5K | Jun 7, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| IKNA | Ikena Oncology, Inc. | Jun 7, 2024 | 1 | $0 | 4 | Jun 10, 2024 | Director |
| IKNA | Ikena Oncology, Inc. | Jun 9, 2023 | 1 | $0 | 4 | Jun 13, 2023 | Director |
| KRON | Kronos Bio, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 29, 2022 | Director |
| IKNA | Ikena Oncology, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
| IKNA | Ikena Oncology, Inc. | Dec 21, 2021 | 1 | $0 | 4 | Dec 23, 2021 | Director |
| KRON | Kronos Bio, Inc. | Jun 22, 2021 | 1 | $0 | 4 | Jun 23, 2021 | Director, 10%+ Owner |